About Black Diamond Therapeutics, Inc.

Black Diamond Therapeutics, Inc. engages in the biotechnology company that discovers and develops therapeutic agents to target unique oncogenic protein-isoforms. The company was founded by Dr. David M. Epstein and Dr. Elizabeth Buck in 2014 and is headquartered in Cambridge, MA.

At the moment the company doesn't generate any revenue.

On its last earning announcement, the company reported a loss of -2.18$ per share.

The book value per share is 2.22$

Black Diamond Therapeutics, Inc. website


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
- - -22M - -28M -2.18 - - 7M 2.22 -20M - -20M